Crossref journal-article
Springer Science and Business Media LLC
Nature Medicine (297)
Bibliography

Ishizaki, J., Nevins, J. R., & Sullenger, B. A. (1996). Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function. Nature Medicine, 2(12), 1386–1389.

Authors 3
  1. Jun Ishizaki (first)
  2. Joseph R. Nevins (additional)
  3. Bruce A. Sullenger (additional)
References 27 Referenced 60
  1. Sherr, C.J. Mammalian G1 cyclins. Cell 73, 1059–1065 (1993). (10.1016/0092-8674(93)90636-5) / Cell by CJ Sherr (1993)
  2. Hunter, T. Braking the cycle. Cell 75, 839–841 (1993). (10.1016/0092-8674(93)90528-X) / Cell by T Hunter (1993)
  3. Nevins, J.R. E2F: A link between the Rb tumor suppressor protein and viral onco-proteins. Science 258, 424–429 (1992). (10.1126/science.1411535) / Science by JR Nevins (1992)
  4. Helin, K. & Harlow, E. The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol. 3, 43–46 (1993). (10.1016/0962-8924(93)90150-Y) / Trends Cell Biol. by K Helin (1993)
  5. La Thangue, N.B. DRTF1/E2F: An expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci. 19, 108–114 (1994). (10.1016/0968-0004(94)90202-X) / Trends Biochem. Sci. by NB La Thangue (1994)
  6. Sherr, C.J. & Roberts, J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149–1163 (1995). (10.1101/gad.9.10.1149) / Genes Dev. by CJ Sherr (1995)
  7. Weinberg, R.A. The retinoblastoma protein and cell cycle control. Cell 81, 323–330 (1995). (10.1016/0092-8674(95)90385-2) / Cell by RA Weinberg (1995)
  8. Gold, L., Polisky, B., Uhlenbeck, O. & Yarus, M. Diversity of oligonucleotide functions. Annu. Rev. Biochem. 64, 763–797 (1995). (10.1146/annurev.bi.64.070195.003555) / Annu. Rev. Biochem. by L Gold (1995)
  9. Szostak, J.W. In vitro genetics. Trends Biochem. Sci. 17, 89–93 (1992). (10.1016/0968-0004(92)90242-2) / Trends Biochem. Sci. by JW Szostak (1992)
  10. Tuerk, C. & Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505–510 (1990). (10.1126/science.2200121) / Science by C Tuerk (1990)
  11. Tuerk, C. & MacDougal-Waugh, S. In vitro evolution of functional nucleic acids: High-affinity RNA ligands of HIV-1 proteins. Gene 137, 33–39 (1993). (10.1016/0378-1119(93)90248-2) / Gene by C Tuerk (1993)
  12. Cress, W.D., Johnson, D.G. & Nevins, J.R. A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4. Mol. Cell. Biol. 13, 6314–6325 (1993). (10.1128/MCB.13.10.6314) / Mol. Cell. Biol. by WD Cress (1993)
  13. Zuker, M. On finding all suboptimal foldings of an RNA molecule. Science 244, 48–52 (1989). (10.1126/science.2468181) / Science by M Zuker (1989)
  14. Jaeger, J.A., Turner, D.H. & Zuker, M. Improved predictions of secondary structures for RNA. Proc. Natl. Acad. Sci. USA 86, 7706–7710 (1989). (10.1073/pnas.86.20.7706) / Proc. Natl. Acad. Sci. USA by JA Jaeger (1989)
  15. Jaeger, J.A., Turner, D.H. & Zuker, M. Predicting optimal and suboptimal secondary structure for RNA. Methods Enzymol. 183, 281–306 (1989). (10.1016/0076-6879(90)83019-6) / Methods Enzymol. by JA Jaeger (1989)
  16. Duronio, R.J., O´Farrell, P.H., Xie, J.-E., Brook, A. & Dyson, N. The transcription factor E2F is required for S phase during Drosophila embryogenesis. Genes Dev. 9, 1445–1455 (1995). (10.1101/gad.9.12.1445) / Genes Dev. by RJ Duronio (1995)
  17. Dobrowolski, S.F., Stacey, D.W., Harter, M.L., Stine, J.T. & Hiebert, S.W. An E2F dominant negative mutant blocks E1A induced cell cycle progression. Oncogene 9, 2605–2612 (1994). / Oncogene by SF Dobrowolski (1994)
  18. Wu, C.-L., Classon, M., Dyson, N. & Harlow, E. Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1 . Mol. Cell. Biol. 16, 3698–3706 (1996). (10.1128/MCB.16.7.3698) / Mol. Cell. Biol. by C-L Wu (1996)
  19. Asano, M., Nevins, J.R. & Wharton, R.P. Ectopic E2F expression induces S phase and apoptosis in Drosophila imaginal discs. Genes Dev. 10, 1422–1432 (1996). (10.1101/gad.10.11.1422) / Genes Dev. by M Asano (1996)
  20. DeGregori, J., Leone, G., Ohtani, K., Miron, A. & Nevins, J.R. E2F1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev. 9, 2873–2887 (1995). (10.1101/gad.9.23.2873) / Genes Dev. by J DeGregori (1995)
  21. Johnson, D.G., Schwarz, J.K., Cress, W.D. & Nevins, J.R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365, 349–352 (1993). (10.1038/365349a0) / Nature by DG Johnson (1993)
  22. Qin, X.-Q., Livingston, D.M., Kaelin, W.G. & Adams, P.D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91, 10918–10922 (1994). (10.1073/pnas.91.23.10918) / Proc. Natl. Acad. Sci. USA by X-Q Qin (1994)
  23. Yamasaki, L. et al Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537–548 (1996). (10.1016/S0092-8674(00)81254-4) / Cell by L Yamasaki (1996)
  24. Field, S.J. et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549–561 (1996). (10.1016/S0092-8674(00)81255-6) / Cell by SJ Field (1996)
  25. Doudna, J.A., Cech, T.R. & Sullenger, B. Selection of an RNA molecule that mimics a major autoantigenic epitope of human insulin receptor. Proc. Natl. Acad. Sci. USA 92, 2355–2359 (1995). (10.1073/pnas.92.6.2355) / Proc. Natl. Acad. Sci. USA by JA Doudna (1995)
  26. Ikeda, M.-A., Jakoi, L. & Nevins, J.R. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA 93, 3215–3220 (1996). (10.1073/pnas.93.8.3215) / Proc. Natl. Acad. Sci. USA by M-A Ikeda (1996)
  27. Li, J.-M., Nichols, M.A., Chandrasekharan, S., Xiong, Y. & Wang, X.-F. Transforming growth factor activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J. Biol. Chem. 270, 26750–26753 (1995). (10.1074/jbc.270.45.26750) / J. Biol. Chem. by J-M Li (1995)
Dates
Type When
Created 21 years ago (Aug. 18, 2004, 9:22 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:23 p.m.)
Indexed 1 month, 1 week ago (July 16, 2025, 9:18 a.m.)
Issued 28 years, 8 months ago (Dec. 1, 1996)
Published 28 years, 8 months ago (Dec. 1, 1996)
Published Print 28 years, 8 months ago (Dec. 1, 1996)
Funders 0

None

@article{Ishizaki_1996, title={Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function}, volume={2}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/nm1296-1386}, DOI={10.1038/nm1296-1386}, number={12}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Ishizaki, Jun and Nevins, Joseph R. and Sullenger, Bruce A.}, year={1996}, month=dec, pages={1386–1389} }